• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Time to include buprenorphine-naloxone combination in the WHO Model List of Essential Medicines.

作者信息

Balhara Yatan Pal Singh

出版信息

J Opioid Manag. 2013 Jul-Aug;9(4):237.

PMID:24380101
Abstract
摘要

相似文献

1
Time to include buprenorphine-naloxone combination in the WHO Model List of Essential Medicines.是时候将丁丙诺啡-纳洛酮组合纳入世界卫生组织基本药物示范清单了。
J Opioid Manag. 2013 Jul-Aug;9(4):237.
2
Use and misuse of opioid replacement therapies: a Queensland study.阿片类药物替代疗法的使用和滥用：昆士兰研究。
Subst Use Misuse. 2012 Jan;47(1):78-85. doi: 10.3109/10826084.2011.629017.
3
In brief: Buprenorphine/naloxone (Zubsolv) for opioid dependence.简而言之：丁丙诺啡/纳洛酮（Zubsolv）用于治疗阿片类药物依赖。
Med Lett Drugs Ther. 2013 Oct 14;55(1427):83.
4
Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.丁丙诺啡 + 纳洛酮：新组合。阿片类药物依赖：无证据表明自我注射风险降低。
Prescrire Int. 2007 Dec;16(92):232-5.
5
Buprenorphine alone or with naloxone: Which is safer?丁丙诺啡单用或与纳洛酮联用：哪种更安全？
J Psychopharmacol. 2018 Mar;32(3):344-352. doi: 10.1177/0269881118756015. Epub 2018 Feb 13.
6
Drugs approved for opiate dependence.已获批用于阿片类药物依赖的药物。
FDA Consum. 2003 Jan-Feb;37(1):6.
7
The diverse clinical uses of opioid receptor drugs.阿片受体药物的多种临床用途。
J Psychosoc Nurs Ment Health Serv. 2010 May;48(5):11-4. doi: 10.3928/02793695-20100408-01.
8
Accessing opiate dependence treatment medications: buprenorphine products in an office-based setting.获取阿片类药物依赖治疗药物：基于办公室环境中的丁丙诺啡产品。
Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S103-4. doi: 10.1016/s0376-8716(03)00063-2.
9
The clinical efficacy and abuse potential of combination buprenorphine-naloxone in the treatment of opioid dependence.丁丙诺啡 - 纳洛酮联合用药治疗阿片类物质依赖的临床疗效及滥用可能性
Expert Opin Pharmacother. 2009 Oct;10(15):2537-44. doi: 10.1517/14656560903213405.
10
Medicines and the drug control treaties: is buprenorphine for opioid addiction at risk of being lost?药品与药物管制条约：用于阿片类药物成瘾的丁丙诺啡会面临流失风险吗？
Hum Psychopharmacol. 2004 Jun;19(4):215-24. doi: 10.1002/hup.588.

引用本文的文献

1
Pilot randomized controlled trial of a hospital-based substance use treatment and recovery team (START) to improve initiation of medication for alcohol or opioid use disorder and linkage to follow-up care.基于医院的物质使用治疗和康复团队（START）改善酒精或阿片类药物使用障碍药物治疗起始和随访护理衔接的试点随机对照试验。
J Subst Use Addict Treat. 2023 Jul;150:209063. doi: 10.1016/j.josat.2023.209063. Epub 2023 May 6.
2
National List of Essential Medicines in India: A Story of Deprivation of Substance Use Disorder Treatment.印度基本药物目录：物质使用障碍治疗被忽视的情况
Indian J Psychol Med. 2021 Nov;43(6):531-534. doi: 10.1177/0253717620972942. Epub 2020 Dec 7.
3
Canadian clinical practice guidelines for the use of plant-based cannabis and cannabinoid-based products in the management of chronic non-cancer pain and co-occurring conditions: protocol for a systematic literature review.
加拿大临床实践指南：基于植物的大麻和大麻素类产品在慢性非癌症疼痛及合并症管理中的应用：系统文献综述方案。
BMJ Open. 2020 May 24;10(5):e036114. doi: 10.1136/bmjopen-2019-036114.
4
Initiation and engagement as mechanisms for change caused by collaborative care in opioid and alcohol use disorders.协作式照护在阿片类药物和酒精使用障碍中引发改变的启动和参与机制。
Drug Alcohol Depend. 2018 Nov 1;192:67-73. doi: 10.1016/j.drugalcdep.2018.07.027. Epub 2018 Sep 5.
5
Sustaining alcohol and opioid use disorder treatment in primary care: a mixed methods study.维持初级保健中的酒精和阿片类药物使用障碍治疗：一项混合方法研究。
Implement Sci. 2018 Jun 18;13(1):83. doi: 10.1186/s13012-018-0777-y.
6
Patient predictors of substance use disorder treatment initiation in primary care.患者预测因素在初级保健中物质使用障碍治疗的启动。
J Subst Abuse Treat. 2018 Jul;90:64-72. doi: 10.1016/j.jsat.2018.04.004. Epub 2018 Apr 28.
7
Assessing and improving organizational readiness to implement substance use disorder treatment in primary care: findings from the SUMMIT study.评估并提高基层医疗中实施物质使用障碍治疗的组织准备度：来自SUMMIT研究的结果
BMC Fam Pract. 2017 Dec 21;18(1):107. doi: 10.1186/s12875-017-0673-6.
8
An organizational readiness intervention and randomized controlled trial to test strategies for implementing substance use disorder treatment into primary care: SUMMIT study protocol.一项组织准备度干预及随机对照试验，以测试在初级保健中实施物质使用障碍治疗的策略：SUMMIT研究方案。
Implement Sci. 2015 May 8;10:66. doi: 10.1186/s13012-015-0256-7.
9
Cannabis use among opioid-dependent individuals on opioid substitution therapy.接受阿片类药物替代疗法的阿片类药物依赖个体中的大麻使用情况。
J Pharmacol Pharmacother. 2014 Jul;5(3):203-5. doi: 10.4103/0976-500X.136106.